C4 Therapeutics, Inc. - Common Stock — キャッシュフロー (NASDAQ:CCCC) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

営業活動によるキャッシュフロー -67.25 M-86.97 M-105.94 M-106.84 M-65.16 M-98.69 M -95.35 M 投資活動によるキャッシュフロー -190.5 M-189.34 M58.42 M158.35 M-51.27 M-8.6 M -21.57 M 財務活動によるキャッシュフロー 348.93 M171.4 M1.15 M45.49 M45.34 M126.4 M 126.91 M フリーキャッシュフロー -67.25 M-86.97 M-105.94 M-106.84 M-65.16 M-99.3 M -96.02 M

ニュース

Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year?

C4 Therapeutics, Inc. (CCCC) Reports Q1 Loss, Lags Revenue Estimates

LENZ Therapeutics, Inc. (LENZ) Reports Q1 Loss, Beats Revenue Estimates

Dianthus Therapeutics, Inc. (DNTH) Reports Q1 Loss, Lags Revenue Estimates

What's Going On With C4 Therapeutics Stock Thursday? - C4 Therapeutics (NASDAQ:CCCC)

Is C4 Therapeutics (CCCC) Stock Outpacing Its Medical Peers This Year?

Are You Looking for a Top Momentum Pick? Why C4 Therapeutics, Inc. (CCCC) is a Great Choice

Is BrightSpring Health Services, Inc. (BTSG) Stock Outpacing Its Medical Peers This Year?

Barclaysが臨床試験の進展を受けてC4 Therapeuticsの目標株価を引き上げ

Barclays raises C4 Therapeutics stock price target on trial progress

TD Cowen、C4 Therapeuticsに対する買い推奨を継続

TD Cowen reiterates Buy rating on C4 Therapeutics stock